UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2001-10, Vol.19 (19), p.3918-3928

2001

Volltextzugriff (PDF)

A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors

Clinical cancer research, 2014-12, Vol.20 (24), p.6295-6303

2014

Volltextzugriff (PDF)

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer

Investigational new drugs, 2020-06, Vol.38 (3), p.821-830

2020

Volltextzugriff (PDF)

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

Clinical cancer research, 2020-10, Vol.26 (20), p.5348-5357

2020

Volltextzugriff (PDF)

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

Investigational new drugs, 2019-08, Vol.37 (4), p.722-730

2019

Volltextzugriff (PDF)

Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC

Targeted oncology, 2018-02, Vol.13 (1), p.89-98

2018

Volltextzugriff (PDF)

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1316-1323

2000

Volltextzugriff (PDF)

A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3107-3107

2023

Volltextzugriff (PDF)

Phase 1b study of Wnt inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients with previously untreated stage IV pancreatic cancer (mPDAC)

Clinical cancer research, 2020-07, Vol.26 (20), p.5348-5357

2020

Volltextzugriff (PDF)

A phase Ib dose escalation study of vantictumab (VAN) in combination with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients with previously untreated stage IV pancreatic cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.249-249

2019

Volltextzugriff (PDF)

A phase Ib study of the anti-cancer stem cell agent demcizumab (DEM) & gemcitabine (GEM) +/- paclitaxel protein bound particles (nab-paclitaxel) in pts with pancreatic cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4118-4118

2015

Volltextzugriff (PDF)

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in patients (pts)with 1 st line non-squamous NSCLC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9023-9023

2016

Volltextzugriff (PDF)

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) +/- nab-paclitaxel in patients with pancreatic cancer

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.341-341

2016

Volltextzugriff (PDF)

A phase 1b study of the anticancer stem cell agent demcizumab (DEM), pemetrexed (PEM), and carboplatin (CARBO) in pts with first-line nonsquamous NSCLC

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2544-2544

2014

Volltextzugriff (PDF)

A first-in-human phase 1 study of anticancer stem cell agent OMP-54F28 (FZD8-Fc), decoy receptor for WNT ligands, in patients with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2505-2505

2014

Volltextzugriff (PDF)

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in pts with 1 st line non-squamous NSCLC

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8045-8045

2015

Volltextzugriff (PDF)

A phase 1b study of the anticancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) with or without paclitaxel protein bound particles (nab-paclitaxel) in patients with pancreatic cancer

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.279-279

2014

Volltextzugriff (PDF)

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

Annals of internal medicine, 1997-02, Vol.126 (4), p.257

1997

Volltextzugriff (PDF)

First-in-human evaluation of the human monoclonal antibody vantictumab (OMP-18R5; anti-Frizzled) targeting the WNT pathway in a phase I study for patients with advanced solid tumors

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2540-2540

2013

Volltextzugriff (PDF)

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

Cancer, 1986-02, Vol.57 (3), p.465-470

1986

Volltextzugriff (PDF)

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 1991-03, Vol.83 (6), p.423-428

1991

Volltextzugriff (PDF)

A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC)

Advances in experimental medicine and biology, 1996, Vol.394, p.105

1996

Volltextzugriff (PDF)

A phase II study of constant‐infusion floxuridine for the treatment of metastatic renal cell carcinoma

Cancer, 1993-06, Vol.71 (11), p.3601-3604

1993

Volltextzugriff (PDF)

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma

Cancer, 1994-06, Vol.73 (11), p.2803-2807

1994

Volltextzugriff (PDF)

Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver

Annals of internal medicine, 1984-05, Vol.100 (5), p.736

1984

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(83)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors

Phase 1b study of Wnt inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients with previously untreated stage IV pancreatic cancer (mPDAC)

A phase Ib dose escalation study of vantictumab (VAN) in combination with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients with previously untreated stage IV pancreatic cancer

A phase Ib study of the anti-cancer stem cell agent demcizumab (DEM) & gemcitabine (GEM) +/- paclitaxel protein bound particles (nab-paclitaxel) in pts with pancreatic cancer

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in patients (pts)with 1 st line non-squamous NSCLC

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) +/- nab-paclitaxel in patients with pancreatic cancer

A phase 1b study of the anticancer stem cell agent demcizumab (DEM), pemetrexed (PEM), and carboplatin (CARBO) in pts with first-line nonsquamous NSCLC

A first-in-human phase 1 study of anticancer stem cell agent OMP-54F28 (FZD8-Fc), decoy receptor for WNT ligands, in patients with advanced solid tumors

A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in pts with 1 st line non-squamous NSCLC

A phase 1b study of the anticancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) with or without paclitaxel protein bound particles (nab-paclitaxel) in patients with pancreatic cancer

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

First-in-human evaluation of the human monoclonal antibody vantictumab (OMP-18R5; anti-Frizzled) targeting the WNT pathway in a phase I study for patients with advanced solid tumors

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC)

A phase II study of constant‐infusion floxuridine for the treatment of metastatic renal cell carcinoma

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma

Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver

Suchergebnisse filtern